Abbott Laboratories · Abbott Park, IL United States (NYSE: ABT)
Key Abbott Laboratories Financials
| Company Type | Public -(NYSE: ABT) Headquarters |
|---|---|
| Fiscal Year-End | December |
| Sales (mil.) | $13,177.6 |
| 2010 Employees | 90,000 |
Abbott Laboratories Stock Quote (NYSE: ABT)
| Latest 02/15/12 16:01:51 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $55.46 | 0.000 | 0.000 | $0.00 | $0.00 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Abbott Laboratories Income Statement
| Dec 99 | Dec 88 | Dec 87 | |
| Revenue | 13,177.6 | 4,937.0 | 4,387.9 |
| Cost of Goods Sold | 5,977.2 | -- | -- |
| Gross Profit | 7,200.4 | 4,937.0 | 4,387.9 |
| Gross Profit Margin | 54.6% | -- | -- |
| SG&A Expense | 2,857.1 | -- | -- |
| Depreciation & Amortization | 828.0 | -- | -- |
| Operating Income | 3,541.6 | -- | -- |
| Operating Margin | 26.9% | --% | --% |
| Nonoperating Income | 34.6 | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 3,396.9 | -- | -- |
| Income Taxes | 951.1 | -- | -- |
| Net Income After Taxes | 2,445.8 | 0.0 | 0.0 |
| Continuing Operations | 2,445.8 | -- | -- |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 2,445.8 | -- | -- |
| Total Net Income | 2,445.8 | 752.0 | 632.6 |
| Net Profit Margin | 18.6% | 15.2% | 14.4% |
| Diluted EPS from Total Net Income | 1.57 | 0.42 | 0.70 |
| Dividends per Share | 0.66 | 0.15 | 0.24 |
All amounts in millions of US Dollars except per share amounts.
Abbott Laboratories Balance Sheet
| Assets | Dec 99 | Dec 88 | Dec 87 |
| Current Assets | |||
| Cash | 608.1 | 582.6 | 519.9 |
| Net Receivables | 2,055.8 | -- | -- |
| Inventories | 1,495.4 | -- | -- |
| Other Current Assets | 2,260.4 | -- | -- |
| Total Current Assets | 6,419.8 | 2,353.0 | 2,155.5 |
| Net Fixed Assets | 4,770.1 | -- | -- |
| Other Noncurrent Assets | 3,281.2 | -- | -- |
| Total Assets | 14,471.0 | 4,825.1 | 4,385.7 |
| Liabilities | Dec 99 | Dec 88 | Dec 87 |
| Current Liabilities | |||
| Accounts Payable | 1,226.9 | -- | -- |
| Short-Term Debt | 896.3 | -- | -- |
| Other Current Liabilities | 2,393.6 | -- | -- |
| Total Current Liabilities | 4,516.7 | 1,439.7 | 1,486.8 |
| Long-Term Debt | 1,336.8 | 349.3 | 271.0 |
| Other Noncurrent Liabilities | 1,189.9 | -- | -- |
| Total Liabilities | 7,043.4 | -- | -- |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | -- | -- |
| Common Stock Equity | 7,427.6 | -- | -- |
| Total Equity | 7,427.6 | 2,464.6 | 2,093.5 |
| Shares Outstanding (thou.) | 1,546,738.4 | 1,798.8 | 906.9 |
All amounts in millions of US Dollars except per share amounts.
Abbott Laboratories Cash Flow Statement
| Dec 99 | Dec 88 | Dec 87 | |
| Net Operating Cash Flow | 2,938 | -- | -- |
| Net Investing Cash Flow | (1,198.2) | -- | -- |
| Net Financing Cash Flow | (1,426.8) | ||
| Net Change in Cash | 292.9 | ||
| Depreciation & Amortization | 828.0 | ||
| Capital Expenditures | (987.1) | ||
| Cash Dividends Paid | (1,003.3) |
All amounts in millions of US Dollars except per share amounts.